Clinical Trial Update: SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for SABR including regional lymph node irradiation in high-risk prostate cancer across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN